Clinical Trials Logo

Clinical Trial Summary

this study aimed to evaluate the corneal endothelial cell changes before and after phacoemulsification in pseudoexfoliative patients relative to healthy adults.


Clinical Trial Description

Pseudoexfoliation syndrome (PEX) is an age related microfibrillopathy disorder characterized by the deposition of greyish white flaky exfoliative material in ocular and extraocular tissue. It commonly affects patients over 50 years old ((commonly in late 60s and 70s) with prevalence range from 0.5% to > 30%, Although it occurs in virtually every area of the world, a considerable racial variation exists in its incidence. It is relatively rare among African Americans and Eskimos. Prevalence is high in the Sami people who are indigenous of northern Europe. There is also a high prevalence in Arabic populations. It is also well known that patients with PXF develop cataracts early in their lives. Phacoemulsification is a preferred type of cataract surgery owing to fewer complications than other types. However, it still has significant undesirable hazardous as Posterior capsular rupture, vitreous loss, Retinal detachment, Cystoid macular oedema and Posterior capsule opacification. Also, it can enhance loss of corneal endothelial cells, thickness and density that may result in corneal decompensation and subsequent corneal transplantation. In patients with PXF, small pupils and weak zonular support may enhance Phacoemulsification complications. Non-contact Specular microscope is a non-invasive method for morphological analysis of corneal density of endothelial cells, "size change" (Polymegathism), "hexagonal change" (pleomorphism). Therefore, this technology plays an important role in preoperative evaluation, surgical design and postoperative care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05194891
Study type Observational
Source Assiut University
Contact Shymaa Ahmed, Doctor
Phone +20 106 319 4646
Email shymaa.sabet@yahoo.com
Status Not yet recruiting
Phase
Start date February 1, 2022
Completion date March 2023

See also
  Status Clinical Trial Phase
Completed NCT03855293 - Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule N/A
Completed NCT04547036 - Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation
Completed NCT05529485 - Quantification of Factors Influencing Endothelial Damage During Phacoemulsification
Recruiting NCT05587205 - Study to Assess Safety and Tolerability of EO2002 Phase 1